Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate and Severe Rheumatoid Arthritis”

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT00996203
What this trial is testing

Tocilizumab Added to DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis and an Inadequate Response to DMARDs.

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 201
Large-scale testing (Phase 3)Study completedNCT00535782
What this trial is testing

The Effect of Tocilizumab on Markers of Atherogenic Risk in Patients With Moderate to Severe Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 132
Not applicableStudy completedNCT01483326
What this trial is testing

An Observational Study on Long-Term Efficacy and Safety of RoActemra/Actemra (Tocilizumab) in Patients With Moderate to Severe Rheumatoid Arthritis (FAct)

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 215
Testing effectiveness (Phase 2)Ended earlyNCT02843659
What this trial is testing

Proof of Concept Study to Evaluate the Efficacy and Safety of BMS-931699 (Lulizumab) or BMS-986142 in Primary Sjögren's Syndrome

Who this might be right for
Sjögren's Syndrome
Bristol-Myers Squibb 45
Post-approval studies (Phase 4)Study completedNCT04928066
What this trial is testing

The Efficacy and Safety of Tofacitinib (TF) With Iguratimod (IGU) on RA

Who this might be right for
Arthritis, Rheumatoid
Qilu Hospital of Shandong University 100
Large-scale testing (Phase 3)Study completedNCT02706873
What this trial is testing

Compare Upadacitinib (ABT-494) Monotherapy to Methotrexate (MTX) Monotherapy in Adults With Rheumatoid Arthritis (RA) Who Have Not Previously Taken Methotrexate

Who this might be right for
Rheumatoid Arthritis
AbbVie 1,002
Post-approval studies (Phase 4)Study completedNCT01034397
What this trial is testing

Tocilizumab Plus Non-biological DMARD in Patients With Moderate to Severe Rheumatoid Arthritis and an Inadequate Response to Non-biological DMARDs

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 54
Not applicableUnknownNCT04449224
What this trial is testing

Comparative Effectiveness of Targeted Therapy in RA Patients

Who this might be right for
Rheumatoid Arthritis
Hanyang University 506
Large-scale testing (Phase 3)Study completedNCT05842213
What this trial is testing

Comparative, Multicenter Study in Subjects with Rheumatoid Arthritis, ALVOFLEX

Who this might be right for
Rheumatoid Arthritis
Alvotech Swiss AG 502
Large-scale testing (Phase 3)Study completedNCT01194414
What this trial is testing

Compare Subcutaneous Versus Intravenous Administration of RoActemra/Actemra (Tocilizumab) in Participants With Moderate to Severe Active Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 1,262
Large-scale testing (Phase 3)Study completedNCT03052322
What this trial is testing

MSB11022 in Moderate to Severe Rheumatoid Arthritis

Who this might be right for
Moderate to Severe Rheumatoid Arthritis
Fresenius Kabi SwissBioSim GmbH 288
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07836660
What this trial is testing

IBI355 in Participants With Moderate-to-Severe Sjögren's Disease

Who this might be right for
Sjögren's Disease
Innovent Biologics (Suzhou) Co. Ltd. 198
Testing effectiveness (Phase 2)Study completedNCT02015520
What this trial is testing

Phase IIB Dose Ranging Study in Subjects With Moderate to Severe Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
CSL Behring 143
Large-scale testing (Phase 3)Study completedNCT00106574
What this trial is testing

Assess the Effect of Tocilizumab + DMARD Therapy on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 1,220
Not applicableStudy completedNCT01117480
What this trial is testing

Real Life Evaluation of Rheumatoid Arthritis in Canadians Taking HUMIRA

Who this might be right for
Moderate-to-severe Rheumatoid Arthritis
AbbVie (prior sponsor, Abbott) 1,013
Testing effectiveness (Phase 2)Ended earlyNCT04035668
What this trial is testing

Evaluate the Safety and Efficacy of LOU064 in Patients With Moderate to Severe Sjögren's Syndrome

Who this might be right for
Sjögren Syndrome
Novartis Pharmaceuticals 73
Not applicableActive Not RecruitingNCT04871919
What this trial is testing

Prospective Observational Study of Filgotinib in Subjects With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Alfasigma S.p.A. 1,304
Testing effectiveness (Phase 2)Study completedNCT01373151
What this trial is testing

Phase IIB Rheumatoid Arthritis Dose Ranging Study for BMS-945429 in Subjects Who Are Not Responding to Methotrexate

Who this might be right for
Rheumatoid Arthritis
CSL Behring 418
Testing effectiveness (Phase 2)Study completedNCT02430909
What this trial is testing

Multiple Dose Study of UCB4940 as add-on to Certolizumab Pegol in Subjects With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
UCB Celltech 159
Large-scale testing (Phase 3)Study completedNCT02955212
What this trial is testing

A Study With Upadacitinib (ABT-494) in Subjects From China and Selected Countries With Moderately to Severely Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Conventional Synthetic Disease-Modifying Anti-Rheumatic Drugs (csDMARDs)

Who this might be right for
Rheumatoid Arthritis (RA)
AbbVie 338
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation